Kamil Ali-Jackson is a director of PDS Biotechnology Corporation.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
RIGEL PHARMACEUTICALS INC
29 May 24
4
PDS Biotechnology Corp
17 Jul 23
4
RIGEL PHARMACEUTICALS INC
12 Jul 23
4
PDS Biotechnology Corp
29 Jun 22
4
RIGEL PHARMACEUTICALS INC
23 May 22
4
Aclaris Therapeutics, Inc.
5 Jan 22
4
RIGEL PHARMACEUTICALS INC
17 Dec 21
3
RIGEL PHARMACEUTICALS INC
17 Dec 21
4
Aclaris Therapeutics, Inc.
22 Nov 21
4
PDS Biotechnology Corp
17 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 May 24 | RIGL Rigel Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 68,750 |
25 May 24 | RIGL Rigel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 0.9075 | 30,000 | 27.23 k | 30,000 |
14 Jul 23 | PDSB PDS Biotechnology | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 5.13 | 9,000 | 46.17 k | 9,000 |
26 May 23 | RIGL Rigel Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 43,750 |
26 May 23 | RIGL Rigel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 30,000 | 39.60 k | 30,000 |